This paper aims to uncover the social relations used to promote genetically modified (GM) crops into new African markets. It unravels the network of corporate actors, development agencies, policy officials, and research scientists that support the unquestioned dominance of GM in Uganda, which houses one of the largest experimental program dedicated to agricultural biotechnology on the continent. Gramscian insights reveal how these constellations of power align to support biotechnology at the expense of other technological possibilities, and how this consensus maintains its position of dominance while remaining largely unquestioned and unchallenged.
No takes yet. Share an insight, caveat, or question.
Matthew A. Schnurr (2013) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: